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Sporadic Burkitt’s Lymphoma (BL) is a highly aggressive form of non-Hodgkin’s lymphoma which requires prompt diagnosis and
treatment. Though usual presentation involves abdominal lymphadenopathy with possible solid organ involvement, sporadic BL
can rarely present with peritoneal lymphomatosis. We present a unique case with rapid evolution of BL presenting as peritoneal
and omental lymphomatosis with hepatic lesions and pelvic and pericardial adenopathy.
1. Background
Burkitt’s lymphoma (BL) is a highly aggressive subtype of B
cell non-Hodgkin’s lymphoma with a doubling time of 24
hours [1]. Sporadic BL is a clinical variant which comprises
<1 percent of adult non-Hodgkin’s lymphomas in the US
[2]. Typical presentation includes abdominal symptoms of
pain and distension secondary to ascites. Mesenteric and
retroperitoneal lymph node enlargement is common. Extra-
nodal involvement most commonly involves the GI tract and
secondarily includes CNS, liver, spleen, kidneys, testis, and
ovaries [1]. Peritoneal lymphomatosis is a rare presentation of
extranodal lymphoma, usually associated with diffuse B cell
lymphoma [3–5].
2. Case Report
An 18-year-old female, without significant medical history,
presentedwith complaints of progressive abdominal pain and
fullness. Additional symptoms included intermittent non-
bloody vomiting, shortness of breath, fatigue, and low grade
fevers. On physical examination, there was mild abdominal
distension with tenderness to palpation in all 4 quadrants. No
palpable masses were noted. No extremity edema was noted,
and no cervical, axillary, or inguinal lymphadenopathy was
present.
On laboratory evaluation, lactate dehydrogenase was
markedly elevated (847U/L) (nL 140–250U/L) with uric acid
(16.3mg/dL) (nL 3–5.8mg/dL). CA 125 level was found to
be 637U/mL (nL < 35). Additional labs were within normal
limits including CBC/diff, BMP, and LFTs.
CT abdomen and US of abdomen performed one month
priorly for similar complaints were without abnormalities.
On repeat imaging during admission, computed tomography
(CT) of the chest, abdomen, and pelvis was significant for
extensive thickening, nodularity, and enhancement of the
peritoneum and omentum, read as consistent with carcino-
matosis (Figures 1–3). Additional findings included multiple
bilobar attenuation hepatic lesions, pelvic and pericardial
adenopathy, and moderate size bilateral pleural effusions.
PET/CT was significant for hypermetabolic activity through-
out peritoneal cavity with omental caking (Figures 4-5).
Hypermetabolic liver lesions were noted with retrosternal
and bilateral iliac chain nodes also suspicious formalignancy.
Peritoneal fluid cytology was consistent with CD10+ B
cell population. Biopsy of omental and peritoneal implants
was consistent with Burkitt’s Lymphoma. Flow cytometry
identified a CD10 positive, kappa-restricted B cell population.
Immunohistochemistry found CD20 positive B cells without
significant expression of BCL-2. Ki-67 was 100%. FISH was
positive for MYC/IGH. EBV was found to be positive. Final
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Figure 1: Contrast enhanced CT, axial view, upper chest. (a) Completed October 2016 with benign findings. (b) Completed November 2016
with moderate size bilateral pleural effusions. (c) Completed June 2017 with benign findings.
(a) (b)
(c)
Figure 2: Contrast enhanced CT, axial view, upper abdomen. (a) Completed October 2016 with benign findings. (b) Completed November
2016 with multiple bilobar low attenuation indeterminate hepatic lesions. (c) Completed June 2017 with benign findings.
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Figure 3: Contrast enhanced CT, axial view,mid abdomen. (a) CompletedOctober 2016 with benign findings. (b) CompletedNovember 2016
with extensive thickening, nodularity, and enhancement of the peritoneum and omentum. (c) Completed June 2017 with benign findings.
diagnosis was Ann Arbor stage IV Burkitt’s lymphoma, with
high-intermediate risk via International Prognostic Index
(IPI) scoring.
Five days after presentation, the patient was started on
R-Hyper-CVAD alternating with intrathecal MTX/Ara-C.
Patient tolerated first 2 cycles well with follow-up PET/CT
showing substantial resolution of patient’s peritoneal involve-
ment of malignancy and resolved liver lesions. Eight months
after initiation of treatment, follow-up PET/CT was consis-
tent with complete response.
3. Discussion
Burkitt’s lymphoma (BL) is a highly aggressive subtype of
B cell non-Hodgkin’s lymphoma with a doubling time of
24 hours [1]. The protooncogene c-MYC on chromosome
8q24 is deregulated in BL allowing for disinhibition of many
cell processes including cell growth, division, and death
by apoptosis [6]. The World Health Organization (WHO)
recognizes three clinical variants according to epidemiology,
presentation, and genetic features: endemic, sporadic, and
immunodeficiency associated [7].
Sporadic BL comprises<1 percent of adult non-Hodgkin’s
lymphomas in the US. Median age of diagnosis is 30 years.
Themajority of patients aremale with a 3 or 4 : 1 male : female
ratio. Sporadic BL is more common among Caucasians than
African or Asian Americans [2].
In adults, sporadic BL typically presents with abdomi-
nal symptoms of pain and distension secondary to ascites.
Mesenteric and retroperitoneal lymph node enlargement is
common. Extranodal involvement commonly includes the
distal ileum, stomach, cecum and/or mesentery, kidney,
testis, CNS, and ovaries [1]. Peritoneal lymphomatosis is a
rare presentation of extranodal lymphoma, usually associated
with diffuse B cell lymphoma [3–5]. On autopsy case series
of disseminated lymphoma, 64 (20%) of 322 cases had
peritoneal and omental disease [8].
Peritoneal thickening is more commonly caused by peri-
toneal carcinomatosis secondary to spread of a primary
mucinous tumor. Alternative diagnoses of peritoneal thick-
ening include malignant peritoneal mesothelioma and tuber-
culous peritonitis [9]. Correct interpretation of peritoneal
and omental thickening is necessary in the setting of BL
given its rapid progression and nonsurgical treatment. When
evaluating peritoneal thickening, radiographic signs which
favor lymphomatosis rather than carcinomatosis include
omental caking with peritoneal and mesenteric soft tissue
nodularity and enhancement [5, 10].
It is interesting to note the elevated CA-125 level
with which the patient presented. CA-125, a transmem-
brane glycoprotein, is derived from the epithelia originating




Figure 4: PET/CT imaging of the body performed in June 2017. (a) Coronal Body. (b) Axial upper abdomen. (c) Axial mid abdomen. (d)
Axial low abdomen. Findings of diffuse and permeative abnormal hypermetabolic activity throughout the cavity corresponding to thickening
and caking of the omentum and small pelvic free fluid. Hypermetabolic activity corresponding to multiple low attenuating liver lesions and
retrosternal iliac chain nodes suspicious for malignancy.
from coelomic (pericardium, pleura, and peritoneum) and
müllerian (fallopian tubal, endometrial, and endocervical)
epithelia [11, 12]. Therefore, the elevation in CA-125 in
this patient was likely secondary to extensive peritoneal
malignancy rather than adnexal malignancy. A similar case
report noting elevated CA-125 in a patient with peritoneal
lymphoma has been reported by Horger et al. [13]. Inclusion
of possible peritoneal sources of CA-125 elevations is crucial
when developing a differential diagnosis.
This case report highlights peritoneal lymphomatosis
as a rare presentation of BL with an emphasis on the
rapidity of progression.ThoughBLoftenpresentswith diffuse
abdominal involvement, to our knowledge, this is the first
case report which is able to provide comparative imaging to
display the rapid growth of tumor. In addition, the case report
serves as a reminder of the importance of prompt histological
confirmation of etiology of peritoneal thickening.
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Figure 5: PET/CT imaging of the body performed in November 2016. (a) Coronal Body. (b) Axial upper abdomen. (c) Axial mid abdomen.
(d) Axial low abdomen. Substantial resolution of patient’s peritoneal involvement of malignancy and other changes suggesting malignancy
noted. Previously noted liver lesions resolved.
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